Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. - Wikidata - wikimedia - TriplyDB

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

http://www.wikidata.org/entity/Q34976021

about

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic Optimal Use of Vaccines for Control of Influenza A Virus in Swine B Cells and Functional Antibody Responses to Combat Influenza Universal immunity to influenza must outwit immune evasion Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine Bringing influenza vaccines into the 21st century.Universal influenza vaccines, a dream to be realized soon.Continuing challenges in influenza.Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.Adenoviral vectors as novel vaccines for influenza.H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.Stalking influenza by vaccination with pre-fusion headless HA mini-stem Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Workshop report: Immunoassay standardisation for "universal" influenza vaccines.Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.Pathogen evolution and the immunological niche.Options and obstacles for designing a universal influenza vaccine Fast vaccine design and development based on correlates of protection (COPs).Animal models for influenza viruses: implications for universal vaccine development Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.Identification and characterization of the constituent human serum antibodies elicited by vaccination.Dueling biological and social contagions.

P2860

Q26744622-555C918A-EC09-4DF0-A599-BC05ED2C1A2A Q26782795-18A6C454-6F53-44F5-8631-6C46ED7C385A Q26783503-D39DB24E-FE27-429A-B522-C81D21FBB3B3 Q26801639-6AF8602C-47E0-4CCE-AFC0-84050B35A6A4 Q26991896-DDEA4AE1-43A9-46C7-A0CB-B6039D9B70B5 Q27330166-A30BC062-43AC-49D2-BDC7-E3D847B2C243 Q28539672-D65C655B-2028-44D2-97D9-0B39D5324C67 Q30207889-D80BF3EE-300C-4D62-8F19-320E3DE90B03 Q30234558-1B518B3E-A19D-4925-A8A6-D2419E3ACFDF Q30357413-9AF51AF3-F501-428F-B6C2-50F4D8F49454 Q30361950-D3FC87DF-9B95-48F6-870F-CD80A6B8934A Q30363190-0E4B351A-27C7-4332-9F3C-7D0E02FD8C5C Q30363595-E5A0DCF5-62FF-49EC-AA8B-399740F0FC4E Q30366045-0A558CD3-E1E1-48DD-92DC-72FE9C5D347A Q30370445-BAA539DB-F515-4246-92AC-ACCA79FCF626 Q30371297-6DD5429F-0036-4CE2-95AD-4C8D0D540A59 Q30376724-A46258E7-5D5A-48FB-9059-C7F9A387C873 Q30384443-55411C16-047E-4C6D-9C00-70750367E2CE Q30385331-371A6931-6CF2-4CA4-8903-CA510791DBB7 Q30386279-C81E1EEA-7C2D-4F7B-BA01-4923846EC551 Q30388011-954E9D3E-4133-47CA-8F7B-D9A46B2AA052 Q30388110-53D87F52-1F17-4F86-8423-FA25B8A02EDF Q30392561-CFE86030-D589-4E5A-AA47-A50A446C4B30 Q30395259-096F4CF4-99F9-46CB-882B-A59681FA70AB Q33619871-FBD814A3-21AA-4356-BA24-253303C0BA3D Q33724743-200BF994-681C-456B-AC39-E6C24DE3A602 Q34057737-7634C368-B926-4EBD-ADDC-015A2C17F04C Q34078369-891C3631-0AB4-4D07-B721-C3D0C399E392 Q34102290-46DBA589-0D89-47B8-85B8-B06B81C1CBC0 Q34291098-7602B4BB-6005-46ED-A1B0-53E5AC787DC3 Q34809686-53A38929-E254-4FCF-B9D4-B44B76DB39E1 Q35839983-1BF47897-71E5-4A5B-8C5F-9A71D3DD0AD6 Q36078779-051E586D-A10D-41F3-A618-56B4132FDEF5 Q36392511-1F5D7474-D0A4-4F35-B5D7-E6074F56ACC2 Q37034798-B78204B0-2B75-4B03-87BA-586A3D339F4E Q37091569-A1E6CADA-3450-454C-AC60-300D704FDF69 Q37197103-24C4F879-4C1B-47E8-9DE5-CF901006FA1B Q37224897-2B70F526-C345-473D-80AA-45EFB387DD48 Q37587683-AC47B12E-322C-4456-ABFE-511308C0A80C Q37677084-3FE31479-375B-4EE3-BF52-5A09B36A13F6

P2860

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

http://www.wikidata.org/entity/Q34976021

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@ast

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@en

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@nl

type

label

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@ast

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@en

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@nl

prefLabel

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@ast

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@en

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@nl

P1433

Q34976021-B63E9072-9DAA-492E-843A-699B046A3509

P1476

Q34976021-1685EC25-916B-43F9-88A0-25744C8941EF

P2093

Q34976021-46FD2421-CB1E-4D33-B85C-71B38A17F1E1

Q34976021-95144EEE-D4F5-4025-9009-0176D4D9F64B

Q34976021-A540033D-BF54-4552-9081-55016B627076

Q34976021-ADD13718-91B4-45D2-970D-B37C52603381

Q34976021-B0B6F7DB-A48A-4347-9048-CFC940F49227

Q34976021-BDED1F6A-EF03-4065-AFF4-6B390B2812DE

Q34976021-C31D7B65-7C8F-476C-AE69-F8508CF32599

Q34976021-F6152CF3-1C63-477F-912A-941ABF623336

P2860

Q34976021-02E2911D-321A-43BD-9141-A285BCEDA4D4

Q34976021-0E730519-5D4C-4C0F-870D-C733020D0678

Q34976021-112C2546-1B21-4BE3-946E-F37B2906CD64

Q34976021-1208FF99-7FFB-4761-81E9-4F00778D7BCD

Q34976021-18A54190-3EDF-47F5-AFAE-F858DD5D91E5

Q34976021-1A5FFD33-0303-4D1A-9519-AD7B85FBB90C

Q34976021-1B67A8D3-5C22-4C4F-802B-E68714CC92AB

Q34976021-3987F103-A12C-42D7-B13C-8888057E9497

Q34976021-3A07BF31-E874-456E-B979-F5B97E6845A5

Q34976021-447229B3-94D2-4236-AA26-6E9603F27654

P304

Q34976021-ACC24DDE-8B9E-4441-B1C1-459872DEEC30

P31

Q34976021-78E985EE-1343-4FBC-81D4-FB01722504E4

P356

Q34976021-F86E31ED-ACFA-4EF1-82BB-E76F65E22002

P407

Q34976021-0D22071B-AEBE-4444-96F7-7165CF4E0A07

P433

Q34976021-3DFC6DBD-270C-405F-B8EE-169E80A96F24

P478

Q34976021-1C174D91-D393-4464-983B-49994B918977

P577

Q34976021-59A35FE8-6AF3-44E9-9367-14A401E29142

P698

Q34976021-647456AB-200F-4FC9-8D15-89A2F7E7C1CC

P921

Q34976021-C430FEDF-8EBD-4337-A353-25F60F9627D1

Q34976021-DEDDA782-8FC3-49A3-A24C-094C69016ACA

P356

SCITRANSLMED.3006366

P1433

Science Translational Medicine

P1476

Vaccine-induced anti-HA2 antib ...... nza virus respiratory disease.

@en

P2093

Amy L Vincent

http://www.w3.org/2001/XMLSchema#string

Crystal L Loving

http://www.w3.org/2001/XMLSchema#string

Hana Golding

http://www.w3.org/2001/XMLSchema#string

Jamie Henningson

http://www.w3.org/2001/XMLSchema#string

Jody Manischewitz

http://www.w3.org/2001/XMLSchema#string

Lisa R King

http://www.w3.org/2001/XMLSchema#string

Phillip C Gauger

http://www.w3.org/2001/XMLSchema#string

Surender Khurana

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Structure of influenza haemagglutinin at the pH of membrane fusion

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

Viral load in patients infected with pandemic H1N1 2009 influenza A virus.

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Perspectives on influenza evolution and the role of research.

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

P304

200ra114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3006366

http://www.w3.org/2001/XMLSchema#string

P407

P433

200

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23986398

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell